Loading clinical trials...
Loading clinical trials...
This is a study to assess long-term safety and efficacy of lersivirine in patients who have completed 96 weeks of treatment with lersivirine in studies A5271015 and A5271022.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
Collaborators
NCT06749054 · HIV-1-infection
NCT06900829 · HIV Infection, HIV, and more
NCT07055451 · HIV-1-infection
NCT05136703 · Depression, HIV-1-infection, and more
NCT06532656 · HIV-1-infection
Pfizer Investigational Site
Darlinghurst, New South Wales
Pfizer Investigational Site
Melbourne, Victoria
Pfizer Investigational Site
Nova Iguaçu, Rio de Janeiro
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions